These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 380252)

  • 21. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea.
    Chan WY
    Annu Rev Pharmacol Toxicol; 1983; 23():131-49. PubMed ID: 6347048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous Membranous Dysmenorrhea in an Adolescent Girl: A Case Report and Literature Review.
    Topçu HO; Topçu S; Kokanalı D; Memur T; Doğanay M
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):e139-41. PubMed ID: 26049935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostasis in menstrual endometrium: a review.
    Christiaens GC; Sixma JJ; Haspels AA
    Obstet Gynecol Surv; 1982 May; 37(5):281-303. PubMed ID: 7048164
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandin content of human endometrium.
    Levitt MJ; Tobon H; Josimovich JB
    Fertil Steril; 1975 Mar; 26(3):296-300. PubMed ID: 1116624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR; Eskes TK
    Ned Tijdschr Geneeskd; 1984 Jan; 128(2):73-8. PubMed ID: 6422313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: a new line on dysmenorphea.
    Br Med J; 1975 May; 2(5969):461-2. PubMed ID: 1148658
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prostaglandins and dysmenorrhea effect of naproxen on prostaglandin concentrations in menstrual blood (author's transl)].
    Ninagawa T; Matsukawa R; Yoshio T; Kan S; Ito K
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):449-54. PubMed ID: 7234342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea.
    Dawood MY
    Am J Med; 1988 May; 84(5A):23-9. PubMed ID: 3287908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA; Baird DT
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1979; 87():39-43. PubMed ID: 111465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders.
    Fraser IS
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):829-57. PubMed ID: 1478000
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
    Mrugacz G; Grygoruk C; Sieczyński P; Grusza M; Pietrewicz P; Pietrzycki B
    Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modern treatment of dysmenorrhea.
    Akerlund M
    Acta Obstet Gynecol Scand; 1990; 69(7-8):563-4. PubMed ID: 2094135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncontraceptive uses of the pill.
    Halbert DR
    Clin Obstet Gynecol; 1981 Sep; 24(3):987-93. PubMed ID: 6456856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysmenorrhea.
    Dawood MY
    J Reprod Med; 1985 Mar; 30(3):154-67. PubMed ID: 3158737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of plants used by Southern African traditional healers in the treatment of dysmenorrhoea for prostaglandin-synthesis inhibitors and uterine relaxing activity.
    Lindsey K; Jäger AK; Raidoo DM; van Staden J
    J Ethnopharmacol; 1999 Jan; 64(1):9-14. PubMed ID: 10075117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
    Lumsden MA; Kelly RW; Baird DT
    Prostaglandins; 1983 May; 25(5):683-92. PubMed ID: 6577521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.
    Joelsson I; Lalos O
    Acta Obstet Gynecol Scand Suppl; 1979; 87():45-49. PubMed ID: 380251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women.
    Lundström V; Gréen K
    Am J Obstet Gynecol; 1978 Mar; 130(6):640-6. PubMed ID: 637076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.